Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PRT543 |
Synonyms | |
Therapy Description |
PRT543 is an inhibitor of PRMT5, which inhibits PRMT5 methyltransferase activity, leading to decreased histone H2A, H3, and H4 arginine mono and di-methylation and altered expression of genes involved in cellular processes, thereby potentially resulting in decreased tumor cell growth (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PRT543 | PRT-543|PRT 543 | PRMT5 Inhibitor 17 | PRT543 is an inhibitor of PRMT5, which inhibits PRMT5 methyltransferase activity, leading to decreased histone H2A, H3, and H4 arginine mono and di-methylation and altered expression of genes involved in cellular processes, thereby potentially resulting in decreased tumor cell growth (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03886831 | Phase I | PRT543 | A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies | Completed | USA | 0 |